Page last updated: 2024-10-27

fenoldopam and Vascular Injuries

fenoldopam has been researched along with Vascular Injuries in 4 studies

Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brott, DA2
Katein, A1
Thomas, H1
Lawton, M1
Montgomery, RR1
Richardson, RJ2
Louden, CS2
Swanson, TA1
Conte, T1
Deeley, B1
Portugal, S1
Kreeger, JM1
Obert, LA1
Joseph, EC1
Wisialowski, TA1
Sokolowski, SA1
Rief, C1
Nugent, P1
Lawton, MP1
Enerson, BE1
Dalmas, DA1
Scicchitano, MS1
Mullins, D1
Hughes-Earle, A1
Tatsuoka, K1
Magid-Slav, M1
Frazier, KS1
Thomas, HC1

Other Studies

4 other studies available for fenoldopam and Vascular Injuries

ArticleYear
Evaluation of von Willebrand factor and von Willebrand factor propeptide in models of vascular endothelial cell activation, perturbation, and/or injury.
    Toxicologic pathology, 2014, Volume: 42, Issue:4

    Topics: Administration, Oral; Amides; Animals; Benzophenones; Biomarkers; Blood Platelets; Dogs; Dopamine; D

2014
Hemodynamic correlates of drug-induced vascular injury in the rat using high-frequency ultrasound imaging.
    Toxicologic pathology, 2014, Volume: 42, Issue:4

    Topics: Animals; Azepines; Drug-Related Side Effects and Adverse Reactions; Fenoldopam; Hemodynamics; Male;

2014
Potential candidate genomic biomarkers of drug induced vascular injury in the rat.
    Toxicology and applied pharmacology, 2011, Dec-01, Volume: 257, Issue:2

    Topics: Animals; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Fenoldop

2011
Evidence for the nitric oxide pathway as a potential mode of action in fenoldopam-induced vascular injury.
    Toxicologic pathology, 2012, Volume: 40, Issue:6

    Topics: Analysis of Variance; Animals; Caspase 3; Caveolin 1; Cell Survival; Fenoldopam; Immunohistochemistr

2012